Use of mutagenesis to probe IGF-binding protein structure/function relationships

被引:136
作者
Clemmons, DR [1 ]
机构
[1] Univ N Carolina, Div Endocrinol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1210/er.22.6.800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The IGF-binding proteins (IGFBPs) are multifunctional proteins that modulate IGF actions. To determine whether specific domains within these proteins account for specific functions, we and other laboratories have used in vitro mutagenesis. Prior experiments that used a variety of techniques had identified discrete regions within each protein that were proposed to account for specific functions. Alterations of these regions by substituting charged residues with neutral residues or hydrophobic residues with nonhydrophobic residues as well as domain swapping, i.e., substituting a domain from one specific form of IGFBP for the homologous domain in another form, has resulted in the elucidation of the functions of many of these specific sequences. Because the areas of protein sequence that are altered involve a limited number of amino acids, they generally do not alter the conformation of the entire protein; therefore, these specific substitutions can often be correlated with the functional changes that occur after mutagenesis. Mutants have been particularly useful for performing functional analyses in which the purified mutant protein is added to a biological test system. In some cases it has been possible to overexpress the mutagenized protein and determine whether the constitutively synthesized, mutant form of IGFBP has altered functional activity. These results have revealed that discrete regions of IGFBP sequence can mediate important and specific functional properties of these proteins.
引用
收藏
页码:800 / 817
页数:18
相关论文
共 155 条
[52]   ISOLATION OF A SOMATOMEDIN-BINDING PROTEIN FROM PRETERM AMNIOTIC-FLUID - DEVELOPMENT OF A RADIOIMMUNOASSAY [J].
DROP, SLS ;
KORTLEVE, DJ ;
GUYDA, HJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (05) :899-907
[53]  
DURHAM SK, 1995, ENDOCRINOLOGY, V136, P1374, DOI 10.1210/en.136.4.1374
[54]   Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum [J].
Durham, SK ;
Mohan, S ;
Liu, F ;
Baker, BK ;
Lee, PDK ;
Hintz, RL ;
Conover, CA ;
Powell, DR .
PEDIATRIC RESEARCH, 1997, 42 (03) :335-341
[55]  
DURHAM SK, 1994, J BONE MINER RES, V9, P111
[56]   AN INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING-PROTEIN ENHANCES THE BIOLOGIC RESPONSE TO IGF-I [J].
ELGIN, RG ;
BUSBY, WH ;
CLEMMONS, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3254-3258
[57]   Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3 [J].
Firth, SM ;
Ganeshprasad, U ;
Baxter, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2631-2638
[58]  
FIRTH SM, 1995, PROG GROWTH FACTOR R, V6, P233
[59]   Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain [J].
Forbes, BE ;
Turner, D ;
Hodge, SJ ;
McNeil, KA ;
Forsberg, G ;
Wallace, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4647-4652
[60]   EVIDENCE FOR A NOVEL INSULIN-LIKE GROWTH-FACTOR (IGF)-DEPENDENT PROTEASE REGULATING IGF-BINDING PROTEIN-4 IN DERMAL FIBROBLASTS [J].
FOWLKES, J ;
FREEMARK, M .
ENDOCRINOLOGY, 1992, 131 (05) :2071-2076